WhitTier Trust Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5K | Sell |
237
-400
| -63% | -$33.5K | ﹤0.01% | 901 |
|
|
2026
Q1 | $51.7K | Hold |
637
| – | – | ﹤0.01% | 718 |
|
|
2025
Q4 | $54.7K | Sell |
637
-230
| -27% | -$18.9K | ﹤0.01% | 698 |
|
|
2025
Q3 | $66.8K | Sell |
867
-93
| -10% | -$7.27K | ﹤0.01% | 629 |
|
|
2025
Q2 | $75.1K | Buy |
960
+15
| +2% | +$1.12K | ﹤0.01% | 689 |
|
|
2025
Q1 | $68.5K | Buy |
945
+25
| +3% | +$1.79K | ﹤0.01% | 696 |
|
|
2024
Q4 | $68.1K | Sell |
920
-11
| -1% | -$770 | ﹤0.01% | 678 |
|
|
2024
Q3 | $61.4K | Sell |
931
-623
| -40% | -$45.3K | ﹤0.01% | 709 |
|
|
2024
Q2 | $144K | Sell |
1,554
-484
| -24% | -$42.9K | ﹤0.01% | 511 |
|
|
2024
Q1 | $195K | Buy |
2,038
+558
| +38% | +$46.9K | 0.01% | 474 |
|
|
2023
Q4 | $113K | Sell |
1,480
-231
| -14% | -$16.1K | ﹤0.01% | 547 |
|
|
2023
Q3 | $119K | Hold |
1,711
| – | – | ﹤0.01% | 519 |
|
|
2023
Q2 | $161K | Buy |
1,711
+180
| +12% | +$15.6K | 0.01% | 491 |
|
|
2023
Q1 | $127K | Buy |
1,531
+395
| +35% | +$31K | ﹤0.01% | 520 |
|
|
2022
Q4 | $84.8K | Sell |
1,136
-138
| -11% | -$10.6K | ﹤0.01% | 581 |
|
|
2022
Q3 | $105K | Buy |
1,274
+995
| +357% | +$95.7K | ﹤0.01% | 547 |
|
|
2022
Q2 | $27K | Buy |
279
+6
| +2% | +$621 | ﹤0.01% | 770 |
|
|
2022
Q1 | $32K | Hold |
273
| – | – | ﹤0.01% | 737 |
|
|
2021
Q4 | $35K | Sell |
273
-288
| -51% | -$33.6K | ﹤0.01% | 725 |
|
|
2021
Q3 | $64K | Buy |
+561
| New | +$64K | ﹤0.01% | 634 |
|
|
2021
Q2 | – | Sell |
-561
| Closed | -$47K | – | 1002 |
|
|
2021
Q1 | $47K | Sell |
561
-144
| -20% | -$12.2K | ﹤0.01% | 650 |
|
|
2020
Q4 | $64K | Sell |
705
-396
| -36% | -$32.8K | ﹤0.01% | 581 |
|
|
2020
Q3 | $88K | Hold |
1,101
| – | – | 0.01% | 519 |
|
|
2020
Q2 | $76K | Hold |
1,101
| – | – | ﹤0.01% | 520 |
|
|
2020
Q1 | $69K | Buy |
1,101
+396
| +56% | +$28.6K | 0.01% | 512 |
|
|
2019
Q4 | $55K | Hold |
705
| – | – | ﹤0.01% | 580 |
|
|
2019
Q3 | $52K | Hold |
705
| – | – | ﹤0.01% | 589 |
|
|
2019
Q2 | $43K | Hold |
705
| – | – | ﹤0.01% | 610 |
|
|
2019
Q1 | $45K | Hold |
705
| – | – | ﹤0.01% | 601 |
|
|
2018
Q4 | $36K | Buy |
705
+231
| +49% | +$11.7K | ﹤0.01% | 625 |
|
|
2018
Q3 | $28K | Hold |
474
| – | – | ﹤0.01% | 694 |
|
|
2018
Q2 | $23K | Hold |
474
| – | – | ﹤0.01% | 734 |
|
|
2018
Q1 | $22K | Hold |
474
| – | – | ﹤0.01% | 746 |
|
|
2017
Q4 | $18K | Hold |
474
| – | – | ﹤0.01% | 731 |
|
|
2017
Q3 | $17K | Buy |
+474
| New | +$18.1K | ﹤0.01% | 721 |
|
Other funds holding EW
WT
BHIA
NONA
SIM
WhitTier Trust Company's EW Position: Q2 2026 in Review
WhitTier Trust Company reduced its Edwards Lifesciences (EW) stake by 63% in Q2 2026, selling an estimated $33.5K and leaving 237 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #901.
WhitTier Trust Company first reported a position in EW in Q3 2017 and has held it in 35 quarters since. The position peaked at $195K in Q1 2024. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- WhitTier Trust Company held 237 shares of Edwards Lifesciences worth $22.5K as of Q2 2026.
- WhitTier Trust Company sold 400 Edwards Lifesciences shares in Q2 2026, an estimated $33.5K.
- Edwards Lifesciences made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #901 holding.
- WhitTier Trust Company first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 35 quarters since.
- WhitTier Trust Company's Edwards Lifesciences position peaked at $195K in Q1 2024.
- 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.